Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
InChi: InChI=1S/C18H11Cl2NO4/c19-10-6-13(20)15-12(16(18(24)25)21-14(15)7-10)8-11(17(22)23)9-4-2-1-3-5-9/h1-8
220662-95-3 (RJR-2403 oxalate(1:1))
PI3K beta inhibitor GSK2636771 selectively inhibits PI3K beta kinase activity in the PI3K/Akt/mTOR pathway
Formula: C22H26N2O7
25-Dihydroxycholecalciferol
Bivalirudin TFA 161AK1/MAP4K2 inhibitor 1 InChi: InChI=1S/C18H11Cl2NO4/c19-10-6-13(20)15-12(16(18(24)25)21-14(15)7-10)8-11(17(22)23)9-4-2-1-3-5-9/h1-8Bivalirudin TFA is a synthetic 20 residue peptide which reversibly inhibits thrombin. IC50 Value: Target: thrombin in vitro: Eptifibatide (8 mg mL) added together with a low (70 ng mL) concentration of bivalirudin (a direct thrombin inhibitor) effectively (approximately 90%) reduced platelet aggregation induced by thrombin (0. 2 U mL) . In thrombin generation assay (TGA), bivalirudin had no effect on these parameters up to 10 mol l . Bivalirudin
US$ 24.95
US$ 148.50
US$ 148.25
US$ 117.47
US$ 37.00
US$ 304.48
US$ 22.00
US$ 102.75
US$ 13.95
US$ 139.95
US$ 212.47